Emmaus Life Sciences GAAP EPS of -$0.10, revenue of $16.65M

Stock Information for Emmaus Life Sciences Incorporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Emmaus Life Sciences Incorporation

Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements
Emmaus Life Sciences Reports Quarterly Financial Results
Emmaus Life Sciences Reports 2024 Financial Results
Emmaus Life Science Reports Grant of Endari Market Exclusivity In Kingdom of Saudi Arabia
Emmaus Life Sciences Reports Improved Quarterly Financial Results
Emmaus Life Sciences Reports Quarterly Financial Results
Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.